CEACAM1: A key regulator of vascular permeability

Journal of Cell Science

Volumn 123, Issue 24, 2010, Pages 4221-4230

  Nouvion, Anne Laure ^a   Oubaha, Malika ^b   LeBlanc, Sarah ^a   Davis, Elaine C ^c   Jastrow, Holger ^d   Kammerer, Robert ^e   Breton, Valérie ^a   Turbide, Claire ^a   Ergun, Suleyman ^c   Gratton, Jean Philippe ^b   Beauchemin, Nicole ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Angiogenesis; CEACAM1; Cell adhesion; Endothelial; eNOS; SHP 1; Vascular permeability; VEGFR2

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; TUMOR VASCULARIZATION;

MURINAE; MUS;

EID: 78649732136     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.073635     Document Type: Article

References (53)

1. Abou-Rjaily, G. A., Lee, S. J., May, D., Al-Share, Q. Y., Deangelis, A. M., Ruch, R. J., Neumaier, M., Kalthoff, H., Lin, S. H. and Najjar, S. M. (2004). CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation. J. Clin. Invest. 114, 944-952.
2. Ackah, E., Yu, J., Zoellner, S., Iwakiri, Y., Skurk, C., Shibata, R., Ouchi, N., Easton, R. M., Galasso, G., Birnbaum, M. J. et al. (2005). Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119-2127.
3. Beauchemin, N., Kunath, T., Robitaille, J., Chow, B., Turbide, C., Daniels, E. and Veillette, A. (1997). Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 14, 783-790. (Pubitemid 27100022)
4. Bhattacharya, R., Kwon, J., Wang, E., Mukherjee, P. and Mukhopadhyay, D. (2008). Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J. Mol. Signal. 3, 8.
5. Blanes, M. G., Oubaha, M., Rautureau, Y. and Gratton, J. P. (2007). Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J. Biol. Chem. 282, 10660-10669. (Pubitemid 47093458)
6. Brummer, J., Neumaier, M., Gopfert, C. and Wagener, C. (1995). Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 11, 1649-1655.
7. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
8. Chen, Z., Chen, L., Qiao, S. W., Nagaishi, T. and Blumberg, R. S. (2008). Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70. J. Immunol. 180, 6085-6093.
9. Cirino, G., Fiorucci, S. and Sessa, W. C. (2003). Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol. Sci. 24, 91-95.
10. Davis, E. C. (1993). Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. Lab. Invest. 68, 89-99.
11. Dubois, M. J., Bergeron, S., Kim, H. J., Dombrowski, L., Perreault, M., Fournes, B., Faure, R., Olivier, M., Beauchemin, N., Shulman, G. I. et al. (2006). The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat. Med. 12, 549-556.
12. Duval, M., Le Boeuf, F., Huot, J. and Gratton, J. P. (2007). Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol. Biol. Cell 18, 4659-4668. (Pubitemid 350060190)
13. Ergun, S., Kilik, N., Ziegeler, G., Hansen, A., Nollau, P., Gotze, J., Wurmbach, J. H., Horst, A., Weil, J., Fernando, M. et al. (2000). CEA-related cell adhesion molecule 1, a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol. Cell 5, 311-320.
14. Fournes, B., Farrah, J., Olson, M., Lamarche-Vane, N. and Beauchemin, N. (2003). Distinct Rho GTPase activities regulate epithelial cell localization of the adhesion molecule CEACAM1: involvement of the CEACAM1 transmembrane domain. Mol. Cell. Biol. 23, 7291-7304.
15. Fukumura, D., Yuan, F., Endo, M. and Jain, R. K. (1997). Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150, 713-725.
16. Fulton, D., Gratton, J. P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A. and Sessa, W. C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
17. Gray-Owen, S. D. and Blumberg, R. S. (2006). CEACAM1: contact-dependent control of immunity. Nat. Rev Immunol. 6, 433-446.
18. He, H., Venema, V. J., Gu, X., Venema, R. C., Marrero, M. B. and Caldwell, R. B. (1999). Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J. Biol. Chem. 274, 25130-25135.
19. Horst, A. K., Ito, W. D., Dabelstein, J., Schumacher, U., Sander, H., Turbide, C., Brummer, J., Meinertz, T., Beauchemin, N. and Wagener, C. (2006). Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J. Clin. Invest. 116, 1596-1605. (Pubitemid 43911013)
20. Horst, A. K., Bickert, T., Brewig, N., Ludewig, P., van Rooijen, N., Schumacher, U., Beauchemin, N., Ito, W. D., Fleischer, B., Wagener, C. et al. (2009). CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood 113, 6726-6736.
21. Huber, M., Izzi, L., Grondin, P., Houde, C., Kunath, T., Veillette, A. and Beauchemin, N. (1999). The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274, 335-344. (Pubitemid 29035067)
22. Izzi, L., Turbide, C., Houde, C., Kunath, T. and Beauchemin, N. (1999). cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18, 5563-5572.
23. Jones, G. T., Jiang, F., McCormick, S. P. and Dusting, G. J. (2005). Elastic lamina defects are an early feature of aortic lesions in the apolipoprotein E knockout mouse. J. Vasc. Res. 42, 237-246. (Pubitemid 40981130)
24. Kilic, N., Oliveira-Ferrer, L., Wurmbach, J. H., Loges, S., Chalajour, F., Neshat- Vahid, S., Weil, J., Fernando, M. and Ergun, S. (2005). Pro-angiogenic signaling by the endothelial presence of CEACAM1. J. Biol. Chem. 280, 2361-2369.
25. Kilic, N., Oliveira-Ferrer, L., Neshat-Vahid, S., Irmak, S., Obst-Pernberg, K., Wurmbach, J. H., Loges, S., Kilic, E., Weil, J., Lauke, H. et al. (2007). Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 110, 4223-4233.
26. Klaile, E., Vorontsova, O., Sigmundsson, K., Muller, M. M., Singer, B. B., Ofverstedt, L. G., Svensson, S., Skoglund, U. and Obrink, B. (2009). The CEACAM1 N-terminal Ig domain mediates cis- and trans-binding and is essential for allosteric rearrangements of CEACAM1 microclusters. J. Cell Biol. 187, 553-567.
27. Kroll, J. and Waltenberger, J. (1997). The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272, 32521-32527.
28. Lee, K., Forudi, F., Saidel, G. M. and Penn, M. S. (2005). Alterations in internal elastic lamina permeability as a function of age and anatomical site precede lesion development in apolipoprotein E-null mice. Circ. Res. 97, 450-456. (Pubitemid 41298175)
29. Lee, S. J., Heinrich, G., Fedorova, L., Al-Share, Q. Y., Ledford, K. J., Fernstrom, M. A., McInerney, M. F., Erickson, S. K., Gatto-Weis, C. and Najjar, S. M. (2008). Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology 135, 2084-2095.
30. Leung, N., Turbide, C., Olson, M., Marcus, V., Jothy, S. and Beauchemin, N. (2006). Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 25, 5527-5536.
31. Lobo, E. O., Zhang, Z. and Shively, J. E. (2009). CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. J. Leukoc. Biol. 86, 205-218.
32. Montagnani, M., Chen, H., Barr, V. A. and Quon, M. J. (2001). Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J. Biol. Chem. 276, 30392-30398. (Pubitemid 37385124)
33. Muller, M. M., Singer, B. B., Klaile, E., Obrink, B. and Lucka, L. (2005). Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105, 3925-3934. (Pubitemid 40656138)
34. Muller, M. M., Klaile, E., Vorontsova, O., Singer, B. B. and Obrink, B. (2009). Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src. J. Cell Biol. 187, 569-581.
35. Nagaishi, T., Pao, L., Lin, S. H., Iijima, H., Kaser, A., Qiao, S. W., Chen, Z., Glickman, J., Najjar, S. M., Nakajima, A. et al. (2006). SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25, 769-781. (Pubitemid 46107284)
36. Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M. and Dvorak, H. F. (2008). Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11, 109-119.
37. Najjar, S. M. (2002). Regulation of insulin action by CEACAM1. Trends Endocrinol. Metab. 13, 240-245.
38. Nakagami, H., Cui, T. X., Iwai, M., Shiuchi, T., Takeda-Matsubara, Y., Wu, L. and Horiuchi, M. (2002). Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 22, 238-242.
39. Nouvion, A. L. and Beauchemin, N. (2009). CEACAM1 as a central modulator of metabolism, tumor progression, angiogenesis and immunity. Med. Sci. 25, 247-252.
40. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006). VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371.
41. Pantelic, M., Kim, Y. J., Bolland, S., Chen, I., Shively, J. and Chen, T. (2005). Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immunol. 73, 4171-4179. (Pubitemid 40923159)
42. Potenza, M. A., Addabbo, F. and Montagnani, M. (2009). Vascular actions of insulin with implications for endothelial dysfunction. Am. J. Physiol. Endocrinol. Metab. 297, E568-E577.
43. Poy, M. N., Yang, Y., Rezaei, K., Fernstrom, M. A., Lee, A. D., Kido, Y., Erickson, S. K. and Najjar, S. M. (2002). CEACAM1 regulates insulin clearance in liver. Nat. Genet. 30, 270-276.
44. Sadekova, S., Lamarche-Vane, N., Li, X. and Beauchemin, N. (2000). The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases. Mol. Biol. Cell 11, 65-77. (Pubitemid 30075506)
45. Seo, D. W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B. Y. and Stetler-Stevenson, W. G. (2003). TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114, 171-180.
46. Sessa, W. C. (2004). eNOS at a glance. J. Cell Sci. 117, 2427-2429.
47. Sessa, W. C., Garcia-Cardena, G., Liu, J., Keh, A., Pollock, J. S., Bradley, J., Thiru, S., Braverman, I. M. and Desai, K. M. (1995). The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J. Biol. Chem. 270, 17641-17644.
48. Skubitz, K. M., Campbell, K. D., Ahmed, K. and Skubitz, A. P. (1995). CD66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 155, 5382-5390.
49. Slevogt, H., Zabel, S., Opitz, B., Hocke, A., Eitel, J., N'Guessan, P. D., Lucka, L., Riesbeck, K., Zimmermann, W., Zweigner, J. et al. (2008). CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat. Immunol. 9, 1270-1278.
50. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D. and McDonald, D. M. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511-2514.
51. Tilki, D., Irmak, S., Oliveira-Ferrer, L., Hauschild, J., Miethe, K., Atakaya, H., Hammerer, P., Friedrich, M. G., Schuch, G., Galalae, R. et al. (2006). CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 25, 4965-4974.
52. Xu, E., Dubois, M. J., Leung, N., Charbonneau, A., Turbide, C., Avramoglu, R. K., Demarte, L., Elchebly, M., Streichert, T., Levy, E. et al. (2009). Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1(Ceacam1) promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 150, 3508-3512.
53. Zengin, E., Chalajour, F., Gehling, U. M., Ito, W. D., Treede, H., Lauke, H., Weil, J., Reichenspurner, H., Kilic, N. and Ergun, S. (2006). Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133, 1543-1551. (Pubitemid 43732967)